Abstract
INTRODUCTION
The pathological relationship between chronic inflammation and formation of fibrosis has been established in various organs, including the liver, kidney, lung and pancreas. Although liver fibrosis has been studied extensively, the underlying mechanisms remain unclear and drugs to prevent and treat fibrosis are only partially effective. DNA microarray technology offers an approach to this kind of complex problems, and microarray analyses of the whole liver have been reported for liver fibrosis [1, 2] . However, these analyses did not address the behavior of individual hepatic cell-types and the interactions of hepatic cells during fibrosis. Therefore, in the current study we identified hepatic cell-specific marker genes that could be used to understand the in vivo behavior of each type of hepatic cells during fibrogenesis.
About 70%-80% of hepatic cells are parenchymal hepatocytes, while the non-parenchymal cells are mainly composed of Kupffer cells, hepatic stellate cells (HSC) and sinusoidal endothelial cells (SECs) [3, 4] . Kupffer cells are the resident monocytes in liver, and act in phagocytosis of foreign substances such as microorganisms, as well as management of inflammatory processes. Kupffer cells and infiltrated monocytes and lymphocytes are considered to trigger inflammation in the early phase of hepatitis and then maintain chronic inflammation. HSCs control hepatic and cardiovascular contraction, and produce extracellular matrix (ECM) components and cytokines for repair of organs. HSCs are also believed to have a central role in hepatic fibrosis formation. Hepatocytes fulfill the main functions of the liver, including regulation of nutrition, production of major serum proteins, and elimination of unnecessary materials to maintain homeostasis of the whole body [4] . In the current study, we first examined gene expression profiles of hepatic cells that were isolated at different time points during liver fibrosis. Marker genes specific for different types of hepatic cells were obtained by comparing these profiles and using information from previous studies. DNA microarray data for the whole liver were then interpreted during liver fibrogenesis using the hepatic cell-type specific marker genes. Our results suggest that new pathological properties and intracellular events are associated with each cell type during liver fibrogenesis, and provide candidates for diagnostic markers of liver fibrosis.
MATERIALS AND METHODS

Animals and experimental protocols
Male Sprague-Dawley rats (Charles River Japan, Yokohama, Japan) weighing 160-190 g were housed with unrestricted access to food (CRF-1, Oriental Yeast, Tokyo, Japan) and water in air-conditioned animal quarters with a 12 h light/dark cycle (light between 07:00 and 19:00 h). Hepatic fibrosis was induced by intraperitoneal injection of 0.5% dimethylnitrosamine (DMN; Wako Pure Chemical Industries, Osaka, Japan) at 2 mL/kg of body weight for three consecutive days each week for four weeks. Blood samples were drawn from the inferior vena cava on d 0, 4, 7, 14, 21 and 28, respectively. Liver specimens obtained on these days were dissected and immediately frozen in liquid nitrogen. Fibrosis was confirmed by haematoxylin and eosin (HE) staining of the liver tissue. The hydroxyproline content of liver specimens was determined as previously described by Horie et al [5] . Plasma alanine aminotransferase (ATL) and aspartate aminotransferase (AST) were measured using commercial kits (Fuji Film, Tokyo, Japan), and hyaluronic acid levels were determined using a commercial ELISA kit (Fujirebio, Tokyo, Japan). The animal facilities and protocol were reviewed and approved by the Institutional Animal Care and Use Committee of Ajinomoto Co., Inc.
Preparation of HSCs, inflammatory cells (including Kupffer cells) and hepatocytes
HSCs were isolated from rat liver using the pronasecollagenase digestion method as previously reported [6] . Kupffer cell fraction was prepared with an elutriator, using essentially the same method as previously described [6] , and hepatocytes were isolated as previously described [7] .
Selection of marker genes for hepatic cells
Hepatic cells (HSCs, Kupffer cell fraction and hepatocytes) were isolated from the liver on d 0, 4, 7, 14, 21 and 28 during liver fibrogenesis. The isolated hepatic cells at each time point were subjected to DNA microarray analysis. If the maximum or minimum expression of a gene in hepatocytes was ten times higher or lower than that of the same gene in HSCs and the Kupffer cell fraction, the up-or down-regulated gene was defined as a hepatocyte-specific marker gene. If the maximum or minimum expression of a gene in HSCs was ten times higher or lower than that of the same gene in hepatocytes and three times higher or lower than the same gene in the Kupffer cell fraction, this gene was defined as a HSC-specific marker gene. Similarly, if the maximum or minimum expression of a gene in the Kupffer cell fraction was ten times higher or lower than that of the same gene in hepatocytes and three times higher or lower than the same gene in HSCs, the gene was defined as an inflammatory cell-specific marker gene. An explanation of the use of the term 'inflammatory cell', rather than 'Kupffer cell', was given in the Results section. The ratios used to determine cellular specificity were based on previous reports [8, 9] : the number of hepatocytes was about ten times higher than that of the inflammatory cell fraction or HSCs, while the number of Kupffer cells was similar to that of HSCs. Use of a high ratio improved the definition of cellular specificity, but also decreased the number of marker genes. However, we found that these ratios were the most appropriate for identification of a set of genes for analysis of liver fibrogenesis.
Microarray analysis
RNAs both from frozen liver tissues and from each isolated cell type were prepared using Isogen reagent (Nippon Gene), and the quality and quantity of each RNA sample were assessed using an Agilent Bioanalyzer 2100 (Agilent Technologies, Inc.). RNA samples were reverse-transcribed with a poly (dT) oligonucleotide attached to a T7 promoter and copied into dsDNA (Invitrogen). In vitro RNA transcription was performed to incorporate biotin-labeled ribonucleotides into the cRNA transcripts using a RNA transcript labeling kit (Enzo Biochem). Some of the RNA (15 g) was utilized for hybridization to a rat genome U34A array (Affymetrix) and a quality assay using test 3 array probe chips was performed according to the manufacturer' s protocol. After hybridization and subsequent washing using the Affymetrix Fluidics Station 400, fluorescence signals amplified with streptavidin phycoerythrin were measured using the Affymetrix scanner, and the results were analyzed using the MicroArray suite software. In the whole liver analysis, two rats and two arrays were used at each time point (d 4, 7, 14, 21 and 28) . In the cell-type-specific analysis, one rat which was selected by ALT/AST score and one array were used at each time point (d 4, 7, 14, 21 and 28) .
Statistical analysis
Clustering of K-means was performed using the TIGR MeV (MultiExperiment Viewer) [10] . Gene expression profiles in the chronic phase were clustered into 10 patterns using K-means analysis. Clustered genes with a tendency to temporally decrease (clusters 1, 3 and 10) or increase (clusters 7 and 9) were selected as gene markers that had a strong relationship with fibrogenesis.
RESULTS
Time course of gene expression profiles for the whole liver during fibrogenesis
Administration of DMN for three days induced an inflammatory reaction in liver cells simulating the active phase in hepatitis, and the subsequent lack of administration of DMN for four days was used to simulate the remission phase in hepatitis. Repetition of this cycle led to fibrosis in three or four weeks, as shown in Figure 1 . AST (GOT) and ALT (GPT) increased on the days of DMN administration and decreased on the days during which DMN was not administered (Figure 1 ), but both AST and the hyaluronic acid content in serum, a marker of fibrosis [11] , gradually increased on days without DMN administration. The inflammatory reaction in periods without DMN administration was weaker than that in periods with DMN-administration, but gradually increased in intensity and response. Based on the behavior shown in Figure 1 , gene expression profiles on d 4 (just after a period of DMN administration) were defined as representative of the acute phase response, and those on d 7, 14, 21 and 28 (just before a period of DMN administration) were defined as representative of the chronic phase response.
Marker genes indicating fibrotic activity of HSCs
HSCs were isolated from liver at each time point over the time course of development of DMN-induced fibrosis. Marker genes expressed mainly in HSCs were selected from a DNA microarray analysis, as described in the Materials and Methods, and the selected HSC-specific marker genes are listed in Figure 2 . In addition, HSCs isolated from normal rats were cultured in vitro for 7 d and DNA microarray analysis of these cells was performed on d 0, 4, and 7, respectively. Marker genes identified in isolated HSCs in the DMN-induced fibrosis model showed the same behavior in the in vitro culture, supporting the HSC specificity of the selected marker genes. The behavior of HSC-specific marker genes in vivo during fibrogenesis was analyzed using DNA microarray data for the whole liver at each time point during development of DMN-induced fibrosis. These data could indicate the actual behavior of the marker genes in vivo, since the data from isolated HSCs might contain some bias due to isolation stimuli. The behavior of HSC-specific marker genes is shown in Figure 2 , and supplemental background data are provided in Figure 3 . The genes were separated into 2 groups as shown in Figure 2. Group 1 contained marker genes that were linearly up-regulated during fibrogenesis and in the acute inflammation phase, whereas group 2 contained marker genes that were linearly up-regulated during fibrogenesis but not in the acute inflammation phase. Both groups could be further separated into 2 subgroups. Group 1-1 included marker genes that were linearly up-regulated during fibrogenesis and remained in an up-regulated state on d 28, and group 1-2 included marker genes that were also linearly up-regulated during fibrogenesis but then decreased in expression on d 28. Group 2 was similarly separated into groups 2-1 and 2-2. In summary, two groups of HSC-specific marker genes were identified, one in which the genes responded to inflammatory stimuli and the other in which the genes did not respond to such stimuli. Furthermore, , plasma hyaluronic acid levels (ng/mL, dashed line), and liver hydroxyproline levels (ng/mL, dotted line). The x-axis shows the days of fibrogenesis, and each value on the graph is shown as the mean ± SE, n = 5.
HSC-specific marker genes were found that could identify biological changes in HSCs in the late phase of fibrosis.
Marker genes indicating inflammatory activity in immune cell populations
The Kupffer cell fraction was separated from other hepatic cells at each time point during the course of fibrosis development, and marker genes expressed mainly in the Kupffer cell fraction were selected from the DNA microarray analysis. These marker genes are shown in Figure 4 , and supplemental background data are provided in Figure   5 . Marker genes in the Kupffer cell fraction indicated the presence of other hematopoietic cells, such as mast cells, lymphocytes, erythrocytes and their progenitors in this fraction, as shown in Figures 4 and 5 . Since the source cell population for these marker genes could not be confirmed, a particular hematopoietic cell was postulated to be the source of each marker gene based on previous reports as shown in supplemental Table 1 . These data indicated that the method used for isolation of Kupffer cells was not appropriate in fibrotic liver, although it was effective for isolation of normal liver cells. However, despite this drawback, the marker genes could be used to study the behavior of inflammatory cells during fibrogenesis, and these genes were therefore defined as inflammatory cellspecific marker genes. The behavior of the inflammatory cell-specific marker genes in vivo during fibrogenesis was analyzed using DNA microarray data for the whole liver at each time point during DMN-induced fibrogenesis of marker genes, as summarized in Figures 4 and 5. T he acute phase response was followed by an immunological response, based on the increase in expression of Kupffer cell (or macrophage) markers such as Lyz, Gzmb, and Il1b, as well as surface markers of T cells, such as T-cell receptor, Il2rb, Cd8, Cd76, and Cd45. The up-regulated expression of these genes seemed to indicate activation of Kupffer cells and T lymphocytes, as well as activation of the interaction between these cells, around d 7. Temporary up-regulation of mast cell markers such as chemokines and mast cell proteases indicated the invasion and/or activation of mast cells around d 14, which is of interest since mast cells are known not only to cause acute inflammation, but also to have a role in the induction of chronic inflammation [12] [13] [14] . However, whether activation of mast cells is essential for liver fibrosis is unknown. Peak expression of B cell markers such as immunoglobulin occurred on d 21 or d 28, and therefore activation or invasion of B cells seemed to reach its peak in the late phase. Overall, these results showed that inflammatory cell-specific marker genes could be used to monitor the transition of active inflammatory cell populations in fibrosis, and this sequential activation or invasion of inflammatory cells might be related to the stage of fibrotic progression.
Marker genes indicating damage to hepatocytes
Hepatocytes were separated from other hepatic cells at each time point during the course of DMN-induced fibrogenesis, and marker genes expressed mainly in hepatocytes were selected by DNA microarray analysis. The behavior of hepatocyte-specific marker genes in vivo during fibrogenesis was analyzed using DNA microarray data for the whole liver at each time point during fibrosis development. Marker genes were categorized based on their functions, as shown in Figure 6 . Many abnormally expressed genes were identified and temporal analysis revealed groups of genes showing consistent variation in expression. Gene expression profiles in the chronic phase (d 7, 14, 21 and 28) were clustered into 10 patterns using K-means analysis. Clustered genes with a tendency to temporally decrease (clusters 1, 3 and 10) or increase (clusters 7 and 9) were selected, and then genes were further selected based on a strong correlation coefficient (≥ 0.7 or ≤ -0.7) with fibrosis stage (that is, d 7, 14, 21 and 28). The time courses of expression ratios are shown in Figure 7 as supplemental data. The 41 down-regulated and 19 up-regulated genes that were finally selected are shown in Table 2 . These genes appeared to have a strong relationship with progression of fibrosis, and might also share common regulatory expression mechanisms.
Down-regulation of the expression of Cdo1 and Csad showed a strong relationship with fibrotic stage, while expression of Gsta2 was simultaneously up-regulated. Down-regulation of other metabolic enzymes in sulfurcontaining metabolic pathways is also shown in Figure  6 . These data suggested a broad range of abnormalities in sulfur-containing amino acid metabolic pathways in fibrosis. Regarding other genes, Hao2 and Hpcl2 had a role in fatty acid oxidation in peroxisome, while Amacr was associated with beta-oxidation of pristanoyl-CoA and C27-bile acyl-CoAs. The down-regulation of these genes and other metabolic enzymes related to fatty acid oxidation ( Figure 6 ) suggested abnormalities in the fatty acid oxidation process in fibrosis. The expression of Amacr might be related to that of the nuclear receptor subfamily 0, group B, member 2 (Nr0b2), and changes in NrOb2 expression may affect one of the key molecules in cholesterol biosynthesis. Up-regulation of Gk and down-regulation of Pepck1, PC and Slc37a4 suggested abnormalities in gluconeogenesis, glycogen storage and glycolysis, while down-regulation of Ste and Hsd17b2 suggested an abnormality of estrogen metabolism in the liver. Decreased expression of many Cyp drug metabolism enzymes was also found in progression of fibrosis, and abnormalities in hormonal signaling were suggested by the down-regulation of Inhbe, Ghr and Dio1. These results showed that identification of hepatocyte-specific marker genes could allow analysis of functional changes in fibrosis, and all the identified abnormalities might have major effects on hepatic function. Expression profiles of the whole liver and the isolated Kupffer cell fraction during fibrogenesis were obtained using a rat Genome U34A Array (Affymetrix). www.wjgnet.com The reference numbers correspond to the numbers in Table 4 in the supplementary data. were clustered into 10 patterns using K-means analysis. Clustered genes with a tendency to temporally decrease (clusters 1, 3 and 10) or increase (clusters 7 and 9) were selected as gene markers that had a strong relationship with fibrogenesis. different phases, such as repair in the acute phase response and fibrosis in the chronic phase response. These two groups of HSC marker genes may also be differentially regulated. Marker genes in one group may be expressed both in undifferentiated and in differentiated HSCs, while marker genes in the other group may be expressed mainly in differentiated HSCs. The functional changes associated with differentiation of HSCs during fibrosis are not clear. Schnabel et al [15] have temporally divided the activation process of HSCs into an initiation phase and a perpetuation phase, and HSCs in the initiation phase may play a role in wound healing [16, 17] and are then eliminated by apoptosis [18, 19] , although some HSCs in the initiation phase differentiate into cells in the perpetuation phase. The two kinds of marker genes found in our work may be associated with the two phases.
DISCUSSION
Marker genes for HSCs
In the present study, gene expression in HSCs in vivo was mostly similar to that found in vitro, suggesting that HSCs can be activated and produce ECM with few factors contributed by other cell types. Since HSCs also produce auto-stimulating factors such as TGF-beta, chemokines, PDGF, and IGF-1, our results strongly suggest that HSCs have self-supporting properties and few exogenous factors are required for their activation and differentiation. Even if www.wjgnet.com inflammation induced by virus activation stimulates longterm or weak hepatitis, HSCs may be able to autonomously activate and promote fibrosis, and this property of HSCs may be central to promotion of fibrogenesis. Sancho-Bru et al [20] have recently reported that a culture model of HSCs could not exactly match the activated phenotype found in DNA microarray analysis of isolated HSCs from cirrhotic human livers, because in culture marker genes for HSCs in the perpetuation phase are predominantly expressed, relative to those in the initiation phase. However, isolation of HSCs may also alter the expression of some genes, especially the expression of genes associated with inflammation, as shown in Figures 2 and 4 . Therefore, compared to studies of isolated HSCs, our approach reveals the actual behavior of HSCs in vivo during fibrosis.
Gpc3 has been recently proposed as a serum and histochemical marker for hepatocellular carcinoma [21, 22] , since it is only weakly expressed in hepatocytes in normal and cirrhotic livers. However, in our study, Gpc3 was expressed in isolated HSCs during fibrogenesis, but weakly in cultured HSCs, suggesting that HSCs require extracellular factors for expression of Gpc3 during fibrogenesis, or that Gpc3-expressing cells with abnormal characteristics may contaminate the HSC fraction. The cell type showing expression of Gpc3 requires further study.
Marker genes for inflammatory cells
In the present study, gene expression in the inflammatory cell-fraction indicated the presence of several kinds of hematopoietic cells in this fraction, leading to some uncertainty in the data from the rat fibrosis model. However, the behavior of mast cells is of note, since temporary up-regulation of mast cell markers such as chemokines and mast cell proteases indicated invasion and/or activation of mast cells around d 14. Invasion of a marked number of mast cells could not be detected with HE staining, and therefore the number of invading mast cells must be small. Mast cells not only cause acute inflammation, but also have a role in induction of chronic inflammation [12, 14] , and involvement of mast cells in hepatic fibrosis has been reported [12, [23] [24] [25] . RANTES, a chemokine that is produced by T cells and stimulates mast cells [26, 27] , showed its peak expression on d 14, as shown in Figure 4 . RANTES has been suggested to be a mediator of progression from acute to chronic inflammation in colitis [28] , and further studies are of importance to determine whether RANTES activation of mast cells is essential for liver fibrosis.
Marker genes for hepatocytes DNA microarray analysis of whole liver in experimental animal models of hepatic fibrosis has been reported [1, 2] , and characteristic behavior of hepatocyte-specific marker genes over the time course of fibrogenesis was found in this study. DNA microarray data for the whole liver are similar to those for hepatocytes, since 70% of hepatic cells are hepatocytes [8, 9] , and data on d 28 are generally similar to those in previous reports. However, our temporal data indicate progressive abnormal gene expression in fibrogenesis, including in the early phase of fibrogenesis. Further more, since our data did not contain genes expressed in other hepatic cells, the hepatocyte-specific gene set allowed examination of the molecular network in hepatocytes.
Clustered abnormalities were found in genes associated with metabolism of sulfur-containing amino acids in this study. Similar abnormalities in metabolism of sulfurcontaining amino acids have been reported [29, 30] , and an increase in methionine concentration in blood has been found in cirrhosis [31, 32] , which may be related to changes in gene expression in sulfur-containing amino acid metabolism. Furthermore, S-adenosylmethionine has an important role in methylation, including the methylation of DNA. Since abnormalities likely induce tumorigenesis due to DNA instability, it is of note that long-term suppression of S-adenosylmethionine synthetase increases the risk of tumorigenesis [33] . Glycine methyltransferase also has been implicated in DNA instability [34, 35] , and longterm suppression of this enzyme also has an associated risk of tumorigenesis during liver fibrosis. A metabolite of methionine, homocysteine, is also suspected as a risk factor for cardiovascular disease [36, 37] , and an increase in the concentration of homocysteine has been found in cirrhosis [38] . Abnormal homocysteine metabolism may also have an important role in the pathogenesis of liver failure, including fatty liver, activation of HSCs (i.e., enhancement of fibrosis), cardiovascular disease, and HCC. Finally, biosynthesis of taurine from cysteine may be suppressed, possibly leading to painful muscle cramps, which are a complication of cirrhosis caused by taurine deficiency [39] . Therefore, in summary, it is apparent that abnormalities in sulfur-containing amino acid metabolism can result in development of serious diseases. Down-regulation of enzymes related to beta-oxidation in TAA-induced experimental fibrosis has been reported [29] . Studies of the Aox knockout mouse [40] sug gest that metabolites of fatty acids in beta oxidation accumulate in Gene expression profiles in the chronic phase (d 7, 14, 21 and 28) were clustered into 10 patterns using K-means analysis. Clustered genes that showed a tendency to temporally decrease (clusters 1, 3 and 10) or increase (clusters 7 and 9) were selected, as shown in Table 5 in the supplemental data. Among these genes, those showing a strong relation with fibrogenesis were further selected based on a t-test statistical analysis of the rate of change in expression intensity and the number of days of fibrosis. Hepatocyte-specific gene markers showing a strong relation with fibrogenesis are listed. the liver and stimulate PPAR-alpha, resulting in peroxisome proliferation, and tumorigenesis is a potential risk in longterm administration of PPAR-alpha agonists and in the Aox-1 knockout mouse [40, 41] . Radical accumulation by blocking metabolic enzymes associated with beta-oxidation has been suggested as one explanation of tumorigenesis in Aox knockout mice, and furthermore, microarray analysis of Aox-deficient mice can show up-regulation of Lcn2, a marker of carcinogenesis [42] . Interestingly markers such as Lcn2 and Cd36 were up-regulated in hepatocytes during fibrogenesis and in the inflammatory cell fraction in the late phase in our model. Although tumorigenesis due to PPAR alpha agonist is thought not to occur in humans [41, 43] , abnormalities in lipid metabolism during liver fibrosis may have a role in steatofibrosis and/or enhancement of fibrosis and HCC.
Up-regulation of Gck and down-regulation of Pck1 in hepatocytes suggest a decrease in gluconeogenesis, and suppression of gluconeogenesis has been reported in cirrhosis [44] . A deficiency of Scl37a4 enzyme activity in humans causes glycogen storage disease type 1 (GSD-1) genetic disorders [45] and suppression of this molecule is associated with hepatic steatosis [46] . Abnormalities in metabolism and synthesis of sex hormone have also been found in fibrotic liver, and an increased ratio of estrogen to testosterone in serum induces feminization, which is a complication in cirrhotic males [47] . Abnormality of sex-hor mone metabolism is also related to liver malignancies [48, 49] . Down-regulation of Ghr is also found in hepatocytes, and long-term suppression of growth signals may greatly influence fundamental hepatic vitality and produce abnormal hepatic regeneration. Insensitivity to growth hor mones in cir rhosis has been reported [50, 51] , and administration of growth hormone protects against experimental liver fibrosis [52] . Rgn, a regulator of calcium signaling, may have an important role in regulation of proliferation and apoptosis of hepatocytes, as well as in formation of HCC [53, 54] , and down-regulation of regucalcin in our model suggested a risk of HCC development. An association of Afp, Ste, Mt1a, Lcn2, Abcb1 Cml1 (Nat8) and Ca3 with hepatocellular carcinoma (HCC) formation has also been reported. Accumulation of estrogen in the liver is suspected to promote HCC [55, 56] , and NAT8 polymorphism may be related to HCC [57, 58] . Down-regulation of metallothionein [59] [60] [61] and carbonic anhydrase [62, 63] , up-regulation of Mdr/Tap [64] and Lcn [42, 65] occur in HCC, and proliferation of hepatoma cells is suppressed by over-expression of Rgn [53, 66] . The abnormal expression of all these genes in our model is similar to that in HCC, suggesting the importance of understanding whether such changes in gene expression reflect a tumorigenic environment or even promote tumorigenesis.
Differential regulations of genes involved in key events of liver fibrosis
In addition to the expression profiles of cell type specific marker genes discussed above, we here describe how genes involved in key events of liver fibrogenesis are differentially regulated. Gene expression profiles of the whole liver for different functional categories in liver fibrogenesis, such as ECM synthesis/degradation, inflammation and oxidative stress, are shown in Figure 8 . Since both synthesis and degradation of ECM occur simultaneously, both genes are put together. Figure 8 shows that most genes in each category have a common and mutually correlated expression pattern, showing different regulations for different categories. Most genes of ECM synthesis/ degradation as shown in Figure 8A have a peak of upregulation on d 4 and a following gradual up-regulation along with the progression of fibrosis, and interestingly these genes are classified into group 1 of the HSC -specific genes as shown in Figure 2 . Another type of genes of ECM synthesis/degradation as shown in Figure 8B have no peak on d 4 and only a gradual up-regulation along with the progression of fibrosis, and are classified into group 2 of the HSC-specific genes as shown in Figure 2 . Many genes are also involved in the inflammatory category, and here only some of them are plotted as representative in Figure 8C . Most genes of inflammation have a peak on d 4 or 7 commonly, and are classified in group 1 of the Kupffer cell fraction specfic genes as shown in Figure 4 . Most genes in the catregory of oxidative stress in Figure  8D have a minimum expression on d 4, in contrast to the genes of inflammation having a peak on d 4 or 7, and are involved in hepatocyte specific genes as shown in Figure 6 .
Gene expression profiles viewed from both cell types and functional categories have made more clear image on how the temporal expression pattern are closely associated in terms of both the cell specificity and functions in liver fibrosis, and are regulated differently in different categories but in a mutually correlated manner within the same category.
Pathological overview of the behavior of HSCs, inflammatory cells, and hepatocytes in fibrogenesis Our results from gene-expression profiling using hepatic cell-specific marker genes support the hypothesis shown in Figure 9 . Comparisons of gene expression in HSCs in vivo and in vitro strongly suggest that HSCs have self-supporting properties and that few exogenous molecules are required to activate and differentiate HSCs. Hepatocytes have been shown to suffer from serious stress during fibrogenesis, and signals from suppressed hepatocytes, such as radicals, prophlogistic substances and toxic metabolites due to abnormal metabolism, are able to stimulate Kupffer cells and HSCs, leading to subsequent production of HSC-stimulating-factors such as TNF-α and IL-1 by Kupffer cells. Therefore, HSCs, Kupffer cells and other inflammatory cells produce factors such as TGF-beta that suppress hepatocyte vitality and result in hepatocyte injury. Sequential activation of inflammatory cells such as lymphocytes and mast cells may be essential in this process, and even if this stimulatory circuit is small in scale during early remission of fibrogenesis, it can be maintained with appropriate stimulation even at long intervals, with small-scale inflammation induced by C-type hepatitis virus propagation. The self-supporting characteristics of HSCs may have a central role in maintenance of this circuit. Table 1 ; C: genes of inflammation involved in the Kupffer cell fraction as shown in Table 3 ; D: genes of oxidative stress involved in the hepatocytes as shown in Table 6 . 
